Global quality assessment of liver allograft C4d staining during acute antibody-mediated rejection in formalin-fixed, paraffin-embedded tissue.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human Pathology

• Publication date

  2017-12-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.humpath.2017.12.007PMID 29288041
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proposed Diagnostic Criteria for Chronic Antibody‐Mediated Rejection in Liver Allografts

  2016cited by this paper
• Functional Immune Anatomy of the Liver—As an Allograft

  2016cited by this paper
• 2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody‐Mediated Rejection

  2016cited by this paper
• De Novo Donor‐Specific HLA Antibodies Decrease Patient and Graft Survival in Liver Transplant Recipients

  2013cited by this paper
• Impact of donor-specific antibodies on results of liver transplantation

  2013cited by this paper
• Sinusoidal C4d deposits in liver allografts indicate an antibody‐mediated response: Diagnostic considerations in the evaluation of liver allografts

  2012cited by this paper
• Bortezomib for Acute Antibody‐Mediated Rejection in Liver Transplantation

  2012cited by this paper
• Pros and cons for C4d as a biomarker.

  2012influential reference
• Antibody-mediated rejection in the liver allograft

  2012cited by this paper
• The Significance of Donor‐Specific HLA Antibodies in Rejection and Ductopenia Development in ABO Compatible Liver Transplantation

  2011cited by this paper
• Liver allograft antibody‐mediated rejection with demonstration of sinusoidal C4d staining and circulating donor‐specific antibodies

  2011influential reference
• Monomeric C‐reactive protein modulates classic complement activation on necrotic cells

  2011cited by this paper
• Regulation of hepatic blood flow: the hepatic arterial buffer response revisited.

  2010cited by this paper
• The utility of C4d, C9, and troponin T immunohistochemistry in acute myocardial infarction.

  2010cited by this paper
• Current views on rejection pathology in liver transplantation

  2010cited by this paper
• Humoral and cellular rejection after combined liver–kidney transplantation in low immunologic risk recipients

  2009cited by this paper
• Intrahepatic Complement Activation, Sinusoidal Endothelial Injury, and Lactic Acidosis Are Associated With Initial Poor Function of the Liver After Transplantation

  2008cited by this paper
• Significance of C4d staining in ABO-identical/compatible liver transplantation

  2007cited by this paper
• C4d immunopositivity is uncommon in ABO‐compatible liver allografts, but correlates partially with lymphocytotoxic antibody status

  2007cited by this paper
• Acute humoral rejection and C4d immunostaining in ABO blood type‐incompatible liver transplantation

  2006cited by this paper
• Isolated Donor Specific Alloantibody‐Mediated Rejection after ABO Compatible Liver Transplantation

  2006cited by this paper
• Late humoral rejection in a compliant ABO-compatible liver transplant recipient.

  2006cited by this paper
• A case of acute humoral rejection in liver transplantation: successful treatment with plasmapheresis and mycophenolate mofetil

  2005cited by this paper
• Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.

  1999cited by this paper
• Increased risk of antibody-mediated rejection of reduced-size liver allografts.

  1999cited by this paper
• A positive crossmatch in liver transplantation--no effect or inappropriate analysis? A prospective study.

  1997cited by this paper
• Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.

  1994cited by this paper
• High one‐month liver graft failure rates in flow cytometry crossmatch‐positive recipients

  1994cited by this paper
• Probable antibody-mediated failure of two sequential ABO-compatible hepatic allografts in a single recipient.

  1993cited by this paper
• Evidence that the liver does not always protect the kidney from hyperacute rejection in combined liver-kidney transplantation across a positive lymphocyte crossmatch.

  1990cited by this paper
• INFLUENCE OF POSITIVE LYMPHOCYTE CROSSMATCH AND HLA MISMATCHING ON VANISHING BILE DUCT SYNDROME IN HUMAN LIVER ALLOGRAFTS

  1988cited by this paper
• Antibody deposition in liver allografts with chronic rejection.

  1987cited by this paper
• The antibody crossmatch in liver transplantation.

  1986cited by this paper
• A simple micro cytotoxicity test.

  1969cited by this paper

• Evaluating diagnosis and clinical outcome for antibody-mediated rejection in liver transplantation: performance of the 2016 Banff Working Group criteria.

  2026cites this paper
• Molecular signatures discriminating different types of rejection in human liver transplants

  2025cites this paper
• Serum and tissue biomarkers of plasma-cell rich rejection in liver transplant recipients.

  2024cites this paper
• Accurate Visualization of C4d Complement Fragment in Immunohistochemistry by C-Terminal Linear Neoepitope-Specific Antibodies

  2024cites this paper
• Antibody-Mediated Rejection in Post-Liver Transplant Clinical Care: Are We There Yet for Timely Diagnosis and Treatment?

  2024cites this paper
• Consecutive disruption of intrahepatic bile ducts after ABO-incompatible living-donor re-liver transplantation: A case report

  2024cites this paper
• Molecular signatures of chronic antibody-mediated rejection in human liver transplants

  2024cites this paper
• Morphologic and immunophenotypic evaluation of liver allograft biopsies with contemporaneous serum DSA measurements

  2023cites this paper
• Treatment of donor-specific anti-HLA antibodies-mediated rejection after liver transplantation: A French nationwide retrospective study

  2023cites this paper
• Detailed Analysis of Simultaneous Renal and Liver Allografts in the Presence of DSA

  2023cites this paper
• Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation

  2023cites this paper
• Acute Antibody-Mediated Rejection in Liver Transplant Recipients with Autoimmune Liver Disease: A Clinical and Pathologic Study of 4 Cases

  2022cites this paper
• Recurrent Liver Allograft Injury in Patients With Donor-Derived Malignancy Treated With Immunosuppression Cessation and Retransplantation.

  2022cites this paper
• A comparative histological analysis of early and late graft dysfunction in different time zones following living donor liver transplantation

  2022cites this paper
• Acute Antibody-Mediated Rejection in Liver Transplantation: Impact and Applicability of the Banff Working Group on Liver Allograft Pathology 2016 Criteria.

  2022cites this paper
• Antibody-mediated rejection of the liver allograft: an update and a clinico-pathological perspective.

  2021cites this paper
• Liver Pathology

  2021cites this paper
• Is ABO-Incompatible Living Donor Liver Transplantation Really a Good Alternative for Pediatric Recipients?

  2021cites this paper
• The Landscape of Digital Pathology in Transplantation: From the Beginning to the Virtual E-Slide

  2019influential citation
• Pathology of liver disease: advances in the last 50years.

  2019cites this paper
• Enhancing the Value of Histopathological Assessment of Allograft Biopsy Monitoring.

  2019cites this paper
• Recurrent Idiopathic Liver Allograft Failure.

  2019cites this paper
• Isolated vascular “v” lesions in liver allografts: How to approach this unusual finding

  2018cites this paper